Previous Close | 72.21 |
Open | 72.47 |
Bid | 71.74 x 800 |
Ask | 71.77 x 800 |
Day's Range | 70.97 - 72.56 |
52 Week Range | 48.35 - 74.39 |
Volume | |
Avg. Volume | 6,378,427 |
Market Cap | 105.678B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | 60.42 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.